| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10595908 | Bioorganic & Medicinal Chemistry Letters | 2013 | 27 Pages |
Abstract
By combined in silico screening and cancer viability and tumor cell inhibition assays, we identified a small-molecule compound HM03 with promising inhibitive activity and comparable binding mode with the tetra-peptide YZLP that was derived from a Dnak peptide inhibitor.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Meilan Huang, Zhuo Li, Dawei Li, Steven Walker, Caroline Greenan, Richard Kennedy,